American Journal of Clinical Oncology
American Journal of Clinical Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 93. It has an SJR impact factor of 0,696 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,696.
American Journal of Clinical Oncology focuses its scope in these topics and keywords: patients, cancer, chemotherapy, neoadjuvant, therapy, breast, cell, radiotherapy, physical, stereotactic, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
0,696
H-index
93
Docs (year)
103
Docs 3y
271
Total refs
3456
Cites 3y
438
Citable 3y
251
Cites/Doc 2y
1.67
Ref/Doc
33.55
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Computed Tomography Features of Cerebral Spread of Malignant Melanoma
View moreVIP (Etoposide, Ifosfamide, Cisplatin) in Adult Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors
View moreEpirubicin, Cisplatin, and Raltitrexed in Patients With Advanced Gastric and Hepatobiliary Carcinoma
View moreEfficacy of Zoledronic Acid and Pamidronate in Breast Cancer Patients: A Comparative Analysis of Randomized Phase III Trials
View moreDoes Stereotactic Eligibility for the Treatment of Glioblastoma Cause Selection Bias in Randomized Studies?
View moreDocetaxel Plus Cisplatin as Second-Line Therapy in Metastatic or Recurrent Advanced Gastric Cancer Progressing on 5-Fluorouracil-Based Regimen
View moreDocetaxel Plus 5-Fluorouracil in Locally Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
View moreDaily Low-Dose Subcutaneous Recombinant Interleukin-2 by Alternate Weekly Administration
View moreCorrelation of Serum IL-2, IL-6 and IL-10 Levels With International Prognostic Index in Patients With Aggressive Non-Hodgkin's Lymphoma
View moreCorrelation of Radiation Tolerance Dose of Normal Human Organs With Organ Weight, Blood, and Water Content
View moreContinuous Venous Infusion 5-Fluorouracil and Interferon-a in Pancreatic Carcinoma
View moreConservative Therapy of Breast Cancer
View moreConcurrent 72-Hour Continuous Infusion of Etoposide and Cisplatin in Metastatic Breast Cancer
View moreA Phase II Trial of Didemnin B (NSC #335319) in Patients with Advanced Squamous Cell Carcinoma of the Cervix
View moreCombination of Vinorelbine, Epirubicin, and Cyclophosphamide as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
View moreCNS Listeriosis Confused With Leptomeningeal Carcinomatosis in a Patient With a Malignant Insulinoma
View moreClinicopathologic Correlation of DNA Flow Cytometric Content Analysis (DFCA), Surgical Staging, and Estrogen/Progesterone Receptor Status in Endometrial Adenocarcinoma
View moreClinical Characteristics of Hepatocellular Carcinoma With an Extensive Lymph Node Metastasis at Diagnosis
View moreCase of Thrombotic Thrombocytopenic Purpura Associated With Disseminated Gastric Cancer
View moreCarcinoid Tumor of the Thymus
View moreBroad Clinical Activity of Zoledronic Acid in Osteolytic to Osteoblastic Bone Lesions in Patients With a Broad Range of Solid Tumors
View moreAxillary Node Dissection in Ductal Carcinoma In Situ
View moreAnnouncements
View moreAccelerated Epirubicin-Ifosfamide-Dacarbazine Regimen in Patients with Adult Soft Tissue Sarcomas
View more